Nifty
Sensex
:
:
11813.30
40320.41
45.55 (0.39%)
174.91 (0.44%)

Pharmaceuticals & Drugs - Domestic

Rating :
71/99  (View)

BSE: 506943 | NSE: JBCHEPHARM

1005.60
-1.85 (-0.18%)
27-Oct-2020 | 11:44AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1007.00
  •  1061.00
  •  976.95
  •  1007.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  34447
  •  346.40
  •  1149.90
  •  315.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,783.85
  • 23.63
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,784.94
  • 1.09%
  • 5.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.91%
  • 1.83%
  • 20.73%
  • FII
  • DII
  • Others
  • 7.25%
  • 11.64%
  • 2.64%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.14
  • 7.58
  • 7.87

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.98
  • 12.88
  • 13.65

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.92
  • 11.04
  • 25.28

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.28
  • 17.21
  • 16.73

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.93
  • 2.33
  • 2.32

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.42
  • 10.50
  • 10.20

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
522
446
17%
444
419
6%
429
382
12%
456
435
5%
Expenses
367
350
5%
352
354
-1%
339
304
12%
356
354
1%
EBITDA
155
96
62%
92
65
41%
90
78
15%
100
82
23%
EBIDTM
30%
22%
14%
16%
21%
20%
22%
19%
Other Income
23
13
80%
3
16
-80%
16
16
4%
19
9
116%
Interest
4
1
369%
0
1
-36%
1
1
-35%
1
1
14%
Depreciation
17
16
9%
17
12
50%
17
15
14%
16
15
12%
PBT
157
92
71%
67
68
-2%
88
78
14%
102
75
36%
Tax
38
30
26%
17
21
-21%
22
28
-21%
8
23
-66%
PAT
120
62
92%
50
47
7%
66
50
33%
94
51
82%
PATM
23%
14%
7%
11%
16%
13%
21%
12%
EPS
15.46
8.04
92%
6.48
6.05
7%
8.60
6.46
33%
12.13
6.66
82%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,851
1,775
1,643
1,414
1,368
1,232
1,144
1,022
866
802
891
Net Sales Growth
10%
8%
16%
3%
11%
8%
12%
18%
8%
-10%
 
Cost Of Goods Sold
5,147
631
596
542
552
491
341
414
372
320
277
Gross Profit
-3,297
1,144
1,047
871
816
740
803
608
495
482
614
GP Margin
-178%
64%
64%
62%
60%
60%
70%
59%
57%
60%
69%
Total Expenditure
1,414
1,397
1,337
1,215
1,136
1,026
964
874
760
702
698
Power & Fuel Cost
-
62
63
58
55
55
53
47
40
30
23
% Of Sales
-
3%
4%
4%
4%
4%
5%
5%
5%
4%
3%
Employee Cost
-
323
288
251
217
175
160
144
130
113
125
% Of Sales
-
18%
18%
18%
16%
14%
14%
14%
15%
14%
14%
Manufacturing Exp.
-
141
150
140
131
119
224
102
62
53
61
% Of Sales
-
8%
9%
10%
10%
10%
20%
10%
7%
7%
7%
General & Admin Exp.
-
49
53
54
42
35
32
32
28
31
38
% Of Sales
-
3%
3%
4%
3%
3%
3%
3%
3%
4%
4%
Selling & Distn. Exp.
-
117
114
87
78
73
75
74
56
69
132
% Of Sales
-
7%
7%
6%
6%
6%
7%
7%
6%
9%
15%
Miscellaneous Exp.
-
75
72
82
60
77
79
62
73
86
132
% Of Sales
-
4%
4%
6%
4%
6%
7%
6%
8%
11%
5%
EBITDA
437
378
306
199
232
206
180
148
106
100
192
EBITDA Margin
24%
21%
19%
14%
17%
17%
16%
14%
12%
13%
22%
Other Income
61
51
41
55
50
57
11
38
28
29
6
Interest
6
3
5
3
5
11
7
6
5
24
10
Depreciation
68
66
56
57
47
41
39
28
25
22
23
PBT
414
359
287
194
230
211
146
152
104
83
165
Tax
84
76
93
55
46
50
45
26
24
166
26
Tax Rate
20%
22%
32%
28%
20%
24%
31%
30%
23%
20%
16%
PAT
330
272
193
138
184
161
100
62
79
678
139
PAT before Minority Interest
329
272
194
139
184
161
100
62
79
678
139
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
18%
15%
12%
10%
13%
13%
9%
6%
9%
85%
16%
PAT Growth
57%
41%
40%
-25%
14%
60%
63%
-23%
-88%
387%
 
EPS
42.66
35.19
25.03
17.90
23.81
20.85
12.99
7.96
10.28
87.70
18.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,435
1,480
1,442
1,364
1,184
995
1,043
1,020
970
692
Share Capital
15
16
17
17
17
17
17
17
17
17
Total Reserves
1,420
1,464
1,425
1,347
1,167
978
1,026
1,003
953
674
Non-Current Liabilities
63
65
46
27
31
33
32
40
40
36
Secured Loans
0
0
0
0
0
0
0
0
0
1
Unsecured Loans
0
0
0
0
0
0
0
7
12
12
Long Term Provisions
7
6
10
13
10
12
12
8
8
8
Current Liabilities
516
782
736
693
797
460
276
239
188
271
Trade Payables
124
117
110
99
91
78
61
61
37
50
Other Current Liabilities
144
93
120
122
139
104
98
101
79
61
Short Term Borrowings
32
26
29
49
193
127
82
37
55
133
Short Term Provisions
216
545
477
423
375
152
36
41
17
27
Total Liabilities
2,016
2,329
2,226
2,086
2,014
1,487
1,351
1,300
1,198
999
Net Block
651
621
640
679
440
329
311
334
276
258
Gross Block
1,177
1,085
1,054
1,039
754
602
541
537
457
420
Accumulated Depreciation
526
464
414
359
314
273
230
203
180
162
Non Current Assets
741
741
718
879
832
586
370
356
332
279
Capital Work in Progress
16
15
17
4
135
55
46
5
39
4
Non Current Investment
69
96
50
186
231
185
3
3
3
4
Long Term Loans & Adv.
4
8
10
9
23
18
11
14
13
13
Other Non Current Assets
0
1
1
1
2
0
0
0
0
0
Current Assets
1,276
1,589
1,509
1,207
1,182
901
981
944
866
721
Current Investments
334
361
384
225
247
367
497
395
299
81
Inventories
275
244
214
200
188
150
134
105
101
112
Sundry Debtors
345
308
301
266
273
262
236
191
136
346
Cash & Bank
31
37
30
13
13
25
12
156
220
127
Other Current Assets
291
33
13
14
461
96
102
97
111
55
Short Term Loans & Adv.
272
606
568
488
459
96
101
97
110
55
Net Current Assets
760
807
772
514
385
441
704
704
678
449
Total Assets
2,016
2,329
2,226
2,086
2,014
1,487
1,351
1,300
1,198
999

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
275
194
123
201
140
127
-14
84
880
134
PBT
349
287
194
230
212
146
87
104
843
165
Adjustment
8
24
17
13
-1
39
21
-4
33
17
Changes in Working Capital
9
-51
-47
6
-17
-20
-94
9
167
-16
Cash after chg. in Working capital
366
259
164
249
194
165
14
109
1,044
166
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-91
-65
-41
-48
-53
-38
-28
-24
-164
-32
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
24
-28
-21
-45
-28
-112
-142
-116
-261
-89
Net Fixed Assets
-94
-30
-30
-153
-188
-70
-55
-42
-70
-33
Net Investments
53
-23
-23
68
-14
-61
-102
-96
-214
-61
Others
65
25
32
40
174
19
15
22
23
4
Cash from Financing Activity
-306
-156
-60
-184
-100
-1
12
-31
-526
5
Net Cash Inflow / Outflow
-6
11
43
-28
13
13
-144
-63
93
49
Opening Cash & Equivalents
32
21
-21
7
-5
12
156
220
127
78
Closing Cash & Equivalent
26
32
21
-21
9
25
12
156
220
127

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
186
184
172
161
140
117
123
119
113
81
ROA
13%
9%
6%
9%
9%
7%
5%
6%
62%
15%
ROE
19%
13%
10%
14%
15%
10%
6%
8%
82%
22%
ROCE
24%
20%
14%
17%
18%
13%
8%
10%
92%
23%
Fixed Asset Turnover
1.57
1.54
1.35
1.53
1.82
2.03
1.92
1.76
1.85
2.22
Receivable days
67
68
73
72
79
78
75
68
109
140
Inventory Days
53
51
53
52
50
45
42
43
48
40
Payable days
33
32
34
33
32
28
27
26
27
26
Cash Conversion Cycle
88
86
93
91
97
95
91
85
130
154
Total Debt/Equity
0.02
0.02
0.02
0.04
0.16
0.13
0.09
0.05
0.07
0.25
Interest Cover
108
63
57
44
21
22
16
21
36
17

News Update


  • CCI approves proposal of Tau Investment to acquire shares in JB Chemicals
    27th Aug 2020, 12:35 PM

    The proposed combination envisages acquisition of up to 64.90% of the share capital of JB Chemicals & Pharmaceuticals by Tau Investment

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.